Companies: 10,795·Total market cap: $144.5T
Evolus, Inc.

Evolus, Inc.

EOLSNASDAQHealthcare● Active
$6.69
+$0.02(+0.22%)
Market Cap$440239010
P/E Ratio
52W High$10.62
52W Low$3.86
Overview

Evolus, Inc.(EOLS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · EOLS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.30B$0.27B$0.20B$0.15B$0.10B
Cost of Revenue$0.10B$0.08B$0.06B$0.06B$0.04B
Gross Profit$0.19B$0.18B$0.14B$0.09B$0.06B
Gross Margin %(computed)64.86%68.46%69.54%60.41%56.32%
Operating Expenses
R&D Expenses$0.01B$0.01B$0.02B$0.01B$0.00B
G&A Expenses$0.00B$0.19B$0.16B$0.13B$0.00B
Total Operating Expenses$0.23B$0.22B$0.19B$0.16B$0.10B
Operating Income($0.04B)($0.03B)($0.05B)($0.07B)($0.04B)
Operating Margin %(computed)-12.65%-12.92%-24.36%-43.96%-44.55%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.02B$0.02B$0.01B$0.01B$0.00B
Income Before Tax($0.05B)($0.05B)($0.06B)($0.07B)($0.05B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.05B)($0.05B)($0.06B)($0.07B)($0.05B)
Net Margin %(computed)-17.38%-18.94%-30.52%-50.07%-46.96%
Per Share & EBITDA
EPS (Basic)$-0.80$-0.81$-1.08$-1.33$-0.94
Wtd Avg Shares0.06B0.06B0.06B0.06B0.05B
EBITDA($0.03B)($0.03B)($0.04B)($0.05B)($0.04B)
EBITDA Margin %(computed)-9.71%-9.39%-20.69%-36.24%-39.19%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Evolus, Inc.

关于Evolus, Inc.(EOLS)损益表

Evolus, Inc.(EOLS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,EOLS实现营收$0.30B,毛利润$0.19B(毛利率64.86%),净利润($0.05B)(净利率-17.38%)。

常见问题

EOLS · 4 问

Evolus, Inc.(EOLS)2025财年营收为$0.30B,同比up11.6%。

EOLS revenueEOLS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08